Nutriband, Inc. (NTRB)
5.76
-0.05
(-0.86%)
USD |
NASDAQ |
Oct 23, 16:00
5.72
-0.04
(-0.69%)
Pre-Market: 20:00
Nutriband Enterprise Value : 66.82M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 66.82M |
| October 22, 2026 | 67.43M |
| October 21, 2026 | 71.44M |
| October 20, 2026 | 67.91M |
| October 19, 2026 | 69.74M |
| October 16, 2026 | 72.41M |
| October 15, 2026 | 73.02M |
| October 14, 2026 | 73.63M |
| October 13, 2026 | 76.06M |
| October 12, 2026 | 67.91M |
| October 09, 2026 | 77.64M |
| October 08, 2026 | 70.34M |
| October 07, 2026 | 78.91M |
| October 06, 2026 | 78.00M |
| October 05, 2026 | 87.60M |
| October 02, 2026 | 85.29M |
| October 01, 2026 | 86.27M |
| September 30, 2026 | 88.21M |
| September 29, 2026 | 97.09M |
| September 28, 2026 | 96.84M |
| September 25, 2026 | 94.05M |
| September 24, 2026 | 106.08M |
| September 23, 2026 | 86.15M |
| September 22, 2026 | 78.97M |
| September 21, 2026 | 91.25M |
| Date | Value |
|---|---|
| September 18, 2026 | 95.63M |
| September 17, 2026 | 89.79M |
| September 16, 2026 | 82.38M |
| September 15, 2026 | 79.70M |
| September 14, 2026 | 80.98M |
| September 11, 2026 | 81.40M |
| September 10, 2026 | 70.71M |
| September 09, 2026 | 67.30M |
| September 08, 2026 | 70.95M |
| September 04, 2026 | 69.37M |
| September 03, 2026 | 65.24M |
| September 02, 2026 | 53.93M |
| September 01, 2026 | 49.62M |
| August 31, 2026 | 49.88M |
| August 28, 2026 | 51.02M |
| August 27, 2026 | 52.96M |
| August 26, 2026 | 51.50M |
| August 25, 2026 | 55.51M |
| August 24, 2026 | 58.92M |
| August 21, 2026 | 53.52M |
| August 20, 2026 | 43.18M |
| August 19, 2026 | 39.95M |
| August 18, 2026 | 38.74M |
| August 17, 2026 | 36.06M |
| August 14, 2026 | 36.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.903B |
| Corcept Therapeutics, Inc. | 8.967B |
| Veru, Inc. | 15.08M |
| Johnson & Johnson | 662.44B |
| Eli Lilly & Co. | 1.245T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.8806M |
| Revenue (Quarterly) | 0.4375M |
| Total Expenses (Quarterly) | 1.318M |
| EPS Diluted (Quarterly) | -0.0724 |
| Gross Profit Margin (Quarterly) | 40.73% |
| Profit Margin (Quarterly) | -201.3% |
| Earnings Yield | -9.99% |
| Normalized Earnings Yield | -9.990 |